Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report
Case Report
[키워드] abrogated
Admission
biochemical
blockade
C-reactive protein
Case report
clinical picture
coronavirus disease
COVID-19
criteria
decrease
described
develop
eight
elevated
ferritin
Fever
FIVE
hemophagocytic lymphohistiocytosis
HLH
hyperinflammation
Hyperinflammatory
IL-6
Immune thrombocytopenia
Immune-mediated
IMPROVE
induce
inflammatory parameter
intensive care
interleukin-6
interleukin-6 receptor
lactate dehydrogenase
majority
Manifestations
measurement
monoclonal antibody
Patient
patient with COVID-19
performed
Pulmonary function
purpura
quantification
Randomized controlled trials
Respirator
Respiratory failure
Respiratory illness
severe COVID-19
Specific
syndrome
therapeutic
thrombotic
Tocilizumab
treated
Treatment
[DOI] 10.1186/s13256-020-02503-9 PMC 바로가기 [Article Type] Case Report
[DOI] 10.1186/s13256-020-02503-9 PMC 바로가기 [Article Type] Case Report